HYPERION DEFI, INC. Proceeds from Stock Options Exercised
HYPERION DEFI, INC. (HYPD) reported Proceeds from Stock Options Exercised of $27.20 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-04-15
- HYPERION DEFI, INC. proceeds from stock options exercised for the quarter ending 2023-12-31 was $0.00.
- HYPERION DEFI, INC. proceeds from stock options exercised for the quarter ending 2023-09-30 was $0.00.
- HYPERION DEFI, INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was -$18.70K, a 171.04% decline year-over-year.
- HYPERION DEFI, INC. proceeds from stock options exercised for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- HYPERION DEFI, INC. proceeds from stock options exercised for fiscal 2023 was $27.20K.
- HYPERION DEFI, INC. proceeds from stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HYPERION DEFI, INC. proceeds from stock options exercised for fiscal 2021 was $203.13K, a 147.23% increase from fiscal 2020.
- HYPERION DEFI, INC. proceeds from stock options exercised for fiscal 2020 was $82.16K, a 85.11% decline from fiscal 2019.
| Period end | Proceeds from Stock Options Exercised 0 month | Proceeds from Stock Options Exercised | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 6 month as first filed | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 9 month as first filed | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $27.20K 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $27.20K 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | $27.20K 10-Q · filed 2024-08-14 | |||||||
| 2022-12-31 | -$18.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.70K derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $18.70K 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | $18.70K 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2022-08-11 | ||||||
| 2021-12-31 | $26.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $73.04K derived: sum of 2 quarters · filed 2023-03-31 | $203.13K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $46.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $176.80K 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | $130.09K 10-Q · filed 2022-08-11 | |||||||
| 2020-12-31 | $30.02K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $82.16K derived: sum of 2 quarters · filed 2022-03-30 | $82.16K derived: sum of 3 quarters · filed 2022-03-30 | $82.16K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $52.14K 10-Q · filed 2020-11-12 | $52.14K derived: sum of 2 quarters · filed 2020-11-12 | $52.14K 10-Q · filed 2021-11-12 | $52.14K derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $67.89K derived: sum of 4 quarters · filed 2021-03-30 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $67.89K derived: sum of 3 quarters · filed 2021-03-30 | $551.78K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $67.89K derived: sum of 2 quarters · filed 2020-11-12 | $551.78K 10-Q · filed 2020-11-12 | $551.78K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $67.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $551.78K 10-Q · filed 2020-08-14 | $551.78K derived: sum of 3 quarters · filed 2020-08-14 | $608.26K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-05-14 | $67.89K 10-Q · filed 2019-11-13 | $67.89K 10-K · filed 2021-03-30 | ||||||
| 2019-03-31 | $483.89K 10-Q · filed 2020-05-14 | $483.89K derived: sum of 2 quarters · filed 2020-05-14 | $540.37K derived: sum of 3 quarters · filed 2020-05-14 | $540.37K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2019-01-02 | $483.89K 10-Q · filed 2019-05-14 | $483.89K 10-K · filed 2021-03-30 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $56.48K derived: sum of 2 quarters · filed 2020-03-30 | $56.48K derived: sum of 3 quarters · filed 2020-03-30 | $56.48K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $56.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $56.48K derived: sum of 2 quarters · filed 2019-11-13 | $56.48K 10-Q · filed 2019-11-13 | $56.48K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $0.00 10-K · filed 2019-03-27 | ||||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |